Conditions: Extravasations of Anthracycline Anti-cancer Agents
Keywords: Extravasation Anthracyclines
Enrollment: 2

Brief summary:
The purpose of this study is to evaluate the efficacy and safety of KDX-0811(Dexrazoxane) in the treatment of accidental extravasation of anthracycline anti-cancer agents.

Detailed description:

Arms:
arm 1: Dexrazoxane should be given once daily for 3 consecutive days. The dose is:

Day 1: 1000 mg/m2, Day 2: 1000 mg/m2, Day 3: 500 mg/m2 (body surface area)

Interventions: intervention 1: Dexrazoxane
Intervention descriptions: intervention 1: None

Protocol document: